News

Investigators found the first evidence of a decline in type 1 diabetes incidence following implementation of the oral rotavirus vaccine into a routine immunization schedule.

The FDA will decide this year whether the once-daily Merck therapies can be marketed as a switch-on drug for patients with suppressed HIV-1.

Investigators are now interested in assessing potential benefits of direct-acting antivirals for HCV patients who previously had liver cancer.

While studies suggest buprenorphine may be the optimal pharmaceutical treatment for NAS, nonpharmacological approaches may be just as effective.

The TactiCath Contact Force Ablation Catheter is used for cardiac ablation procedures.

An Investigational New Drug application was approved to clinically assess AMT-130 as the first potential drug marketed for the neurodegenerative disease.

Statins are already a common therapy among patients with type 2 diabetes. Its cholesterol-lowering benefits may help retain patient vision longer.

Among differing genders and races, Columbia University investigators found females and Asian Americans are the most at-risk to have the undiagnosed condition.

Analysis of past studies shows benefit of inactivated influenza vaccine against A/H1N1pdm09 virus in 2- to 17-year-olds.

The FDA has approved trastuzumab-dttb (Ontruzant) for the treatment of patients with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma in combination with cisplatin and capecitabine or 5-fluorouracil.

The FDA has approved Verily’s Study Watch, a wearable medical device that conducts electrocardiograms (ECGs).

Acrolein levels were significantly elevated in urine and serum in patients with multiple sclerosis compared to healthy controls.

Three newly discovered strains of HCV genotype 7 in Africa, and a genotype 8 in India, complicate the World Health Organization's goal to eradicate HCV.

Older age was associated with a lower likelihood of entering the ICU, but increased risk of death for hospitalized patients with influenza.

Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.

The hypertension medication is again being recalled due to carcinogenic impurities.

The investigative SGLT1/2 dual inhibitor is scheduled to be considered for marketing approval by mid-March.

River blindness and elephantiasis are 2 of the leading causes of global disability.

Overall antibiotic prescriptions have dropped, but short-term postoperative prescriptions have increased in recent years.

University of Washington investigators found great disparities in AEMT-driven death rates among states and age groups.

Increased opioid prescribing correlated with marketing opioid products to physicians, which subsequently correlated with an increase in mortality from overdoses.

A four-year trial assessing the investigative vaccine in about 3000 pregnant women will announce efficacy results later this quarter.

As costs of treating COPD exacerbation continue to burden patients, investigators sought to determine a risk assessment tool that could lead to reduced costs.

Unlike assessments of pediatric patients, healthcare providers do not routinely include the family members or friends in the assessment of older adults—but they should.

Novel epidemiological approach accounting for persons with undiagnosed HCV shows half of cases in US are in 9 states, including 5 in Appalachia.

The FDA Bone, Reproductive, and Urologic Drugs Advisory Committee voted in favor of approving romosozumab for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.

University of Pennsylvania investigators conducted an interim analysis of a year-long study on intraocular injections of a mutation-specific gene therapy when one patient showed dramatic early improvements.